Inhibition of Experimental Metastasis by Castanospermine in Mice: Blockage of Two Distinct Stages of Tumor Colonization by Oligosaccharide Processing Inhibitors

Cancer Research

Volumn 46, Issue 10, 1986, Pages 5215-5222

  Humphries, Martin J ^a,b   Matsumoto, Kazue M ^a   White, Sandra L W ^a   Olden, Kenneth O ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HOWARD UNIVERSITY CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETASTATIC AGENT; CASTANOSPERMINE; ENZYME INHIBITOR; OLIGOSACCHARIDE; SWAINSONINE; TUNICAMYCIN;

ANIMAL MODEL; CANCER CHEMOTHERAPY; GLUCOSIDASE I; INTRAVENOUS DRUG ADMINISTRATION; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY;

ALKALOIDS; ALPHA-GLUCOSIDASES; ANIMAL; CELL ADHESION; CELL SURVIVAL; FIBRONECTINS; LAMININ; LUNG NEOPLASMS; MELANOMA; MICE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; OLIGOSACCHARIDES; PROTEIN CONFORMATION; SUPPORT, U.S. GOV'T, P.H.S.; SWAINSONINE; TUNICAMYCIN;

EID: 0022475489     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Weiss, L. A pathobiologic overview of metastasis. Semin. Oncol., 4: 5-19, 1977.
2. Fidler, I. J., Gersten, D. M., and Hart, I. R. The biology of cancer invasion and metastasis. Adv. Cancer Res., 28:149-250, 1978.
3. Sugarbaker, E. V. Cancer metastasis: a product of tumor-host interactions. Curr. Probl. Cancer, 3: 1-59, 1979.
4. Poste, G., and Fidler, I. J. The pathogenesis of cancer metastasis. Nature (Lond.), 283:139-146, 1980.
5. Nicolson, G. L. Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochim. Biophys. Acta, 695: 113-176, 1982.
6. Liotta, L. A., Rao, C. N., and Barsky, S. H. Tumor invasion and the extracellular matrix. Lab. Invest., 49: 636-649, 1983.
7. Schirrmacher, V. Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. Adv. Cancer Res., 43: 1-73, 1985.
8. Bretscher, M. S. Membrane structure: some general principles. Science (Wash. DC), 181: 622-629, 1973.
9. Rapin, A. M. C., and Burger, M. M. Tumor cell surfaces: general alterations detected by agglutinins. Adv. Cancer Res., 20: 1-91, 1974.
10. Warren, L., Fuhrer, J.P., and Buck, C. A. Surface glycoproteins of cells before and after transformation by oncogenic viruses. Fed. Proc., 32:80-85, 1973.
11. Robbins, J. C., and Nicolson, G. L. Surfaces of normal and transformed cells. In:; F. F. Becker (ed.), Cancer. A Comprehensive Treatise, Vol. 4, pp. 3-54. New York: Plenum Press, 1975.
12. Yogeeswaran, G. Cell surface glycolipids and glycoproteins in malignant transformation. Adv. Cancer Res., 38:289-350, 1983.
13. Bosmann, H. B., Bleber, G.F., Brown, A.E., Case, K.R., Gersten, D. M., Fimmerer, T. W., and Lione, A. Biochemical parameters correlated with tumour cell implantation. Nature (Lond.), 246:487-489, 1973.
14. Yogeeswaran, G., and Salk, P. L. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science (Wash. DC), 212: 1514-1516, 1981.
15. Altevogt, P., Fogel, M., Cheingsong-Popov, R., Dennis, J., Robinson, P., and Schirrmacher, V. Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines. Cancer Res., 43: 5138-5144, 1983.
16. Yogeeswaran, G., Stein, B. S., and Sebastian, H. Altered cell surface organization of gangliosides and sialylglycoproteins of mouse metastatic melanoma variant lines selected in vivo; for enhanced lung implantation. Cancer Res., 38: 1336-1344, 1978.
17. Raz, A., McLellan, W. L. Hart, I. R. Bucana, C. D., Hoyer, L. C., Sela, B. A., Dragsten, P., and Fidler, I. J. Cell surface properties of B16 melanoma variants with differing metastatic potential. Cancer Res., 40: 1645-1651, 1980.
18. Irimura, T., and Nicolson, G. L. Carbohydrate chain analysis by lectin binding to electrophoretically separated glycoproteins from murine B16 melanoma sublines of various metastatic properties. Cancer Res., 44: 791-798, 1984.
19. Kerbel, R. S., Dennis, J. W., Largarde, A. E., and Frost, P. Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants. Metastasis Rev., 1: 99-140, 1982.
20. Gasic, G. J., Gasic, T. B., and Stewart, C. C. Antimetastatic effects associated with platelet reduction. Proc. Natl. Acad. Sci. USA, 61: 46-52, 1968.
21. Hagmar, B., and Norrby, K. Influence of cultivation, trypsinization and aggregation on the transplantibility of melanoma B16 cells. Int. J. Cancer, 77:663-675, 1973.
22. Sinha, B. K., and Goldenberg, G. J. The effect of trypsin and neuraminidase on the circulation and organ distribution of tumor cells. Cancer (Phila.), 34: 1956-1961, 1974.
23. Kijima-Suda, I., Miyamoto, Y., Toyoshima, S., Hoh, M., and Osawa, T. Inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid:nucleoside conjugate having sialyltransferase inhibiting activity. Cancer Res., 46:858-862,1986.
24. Irimura, T., Gonzalez, R., and Nicolson, G. L. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties. Cancer Res., 41: 3411-3418, 1981.
25. Olden, K., Humphries, M. J., and White, S. L. Biochemical effects and cancer therapeutic potential of tunicamycin. In:; R. Reisfeld and S. Sell (eds.), Monoclonal Antibodies and Cancer Therapy, pp. 443-472. New York: Alan R. Liss, Inc., 1985.
26. Takatsuki, A., Kohno, K., and Tamura, G. Inhibition of biosynthesis of polyisoprenol sugars in chick embryo microsomes by tunicamycin. Agric. Biol. Chem., 39: 2089-2091, 1975.
27. Humphries, M. J., Matsumoto, K., White, S.L., and Olden, K. Oligosaccharide modifications by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. Proc. Natl. Acad. Sci. USA, 83: 1752-1756, 1986.
28. Elbein, A. D., Solf, R., Dorling, P.R., and Vosbeck, K. Swainsonine: an inhibitor of glycoprotein processing. Proc. Natl. Acad. Sci. USA, 78:; 7393-7397, 1981.
29. Saul, R., Chambers, J.P., Molyneux, R.J., and Elbein, A. D. Castanospermine, a tetrahydroxylated alkaloid that inhibits beta-glucosidase and beta-glucocerebrosidase. Arch. Biochem. Biophys., 221: 593-597,1983.
30. Miekka, S. I., Ingham, K.C., and Menache, D. Rapid methods for isolation of human plasma fibronectin. Thromb. Res., 27: 1-14, 1982.
31. Fidler, I. J. Selection of successive tumor lines for metastasis. Nat. New Biol., 242: 148-149, 1973.
32. Fidler, I. J. General considerations for studies of experimental cancer metastasis. Methods Cancer Res., 75:399-439,1978.
33. Liotta, L. A., Kleinerman, J., and Saidel, G.M. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res., 36: 889-894, 1976.
34. Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled withl25I-5-iodo-2'-deoxyuridine. J. Natl. Cancer Inst., 45: 773-781, 1970.
35. Nagata, K., Humphries, M.J., Olden, K., and Yamada, K. M. Collagen can modulate cell interactions with fibronectin. J. Cell Biol., 101: 386-394,1985.
36. Yamada, K. M., and Kennedy, D. W. Dual is tic nature of adhesive protein function: flbronectin and its biologically active peptide fragments can autoinhibit flbronectin function. J. Cell Biol., 99:29-36, 1984.
37. Tack, B. F., Dean, J., Eilat, D., Lorenz, P. E., and Schechter, A. N. Tritium labeling of proteins to high specific radioactivity by reductive methylation. J. Biol. Chem., 255: 8842-8847,1980.
38. Pan, Y. T., Hori, H., Saul, R., Sanford, B. A., Molyneux, R. J., and Elbein, A. D. Castanospermine inhibits the processing of the oligosaccharide portion of the influenza viral hemagglutinin. Biochemistry 22: 3975-3984, 1983.
39. Elbein, A. D., Pan, Y. T., Solf, R., and Vosbeck, K. Effect of swainsonine, an inhibitor of glycoprotein processing, on cultured mammalian cells. J. Cell. Physiol., 775:265-275, 1983.
40. Schwarz, R. T., and Datema, R. The lipid pathway of protein glycosylation and its inhibitors: the biological significance of protein-bound carbohydrates. Adv. Carbohydrate Chem. Biochem., 40: 287-379, 1982.
41. Elbein, A. D. Inhibitors of the biosynthesis and processing of /V-linked oligosaccharides. CRC Crit. Rev. Biochem., 16: 21-49, 1984.
42. Liotta, L. A., and Delisi, C. Method for quantitating tumor cell removal and tumor cell-invasive capacity in experimental metastasis. Cancer Res., 37: 4003-4008, 1977.
43. Humphries, M. J., Olden, K., and Yamada, K. M. A synthetic peptide from flbronectin inhibits experimental metastasis of murine melanoma cells. Science (Wash. DC), 233: 467-470, 1986.
44. Yamada, K. M., Akiyama, S.K., Humphries, M. J., Yamada, S.S., and Santoro, S.A. Platelet and fibroblast interactions with flbronectin and other adhesive proteins. In:; G. Jolles, Y-J. Legrand, and A. T. Nurden (eds.), Cell Biology and Pathology of the Platelet Vessel Wall Interaction and of Thrombus Formation. New York: Academic Press, Inc., in press, 1986.
45. Terranova, V. P., Liotta, L. A., Russo, R. G., and Martin, G. R. Role of laminin in the attachment and metastasis of murine tumor cells. Cancer Res., 42: 2265-2269, 1982.
46. Grimstad, I. A., Varani, J., and McCoy, J. P. Contribution of a-D-galactopyranosyl end groups to attachment of highly and low metastatic murine fibrosarcoma cells to various substrates. Exp. Cell Res., 755:345-358,1984.
47. Dennis, J. W., Waller, C. A., and Schirrmacher, V. Identification of asparagine-linked oligosaccharides involved in tumor cell adhesion to laminin and type IV collagen. J. Cell Biol., 99: 1416-1423,1984.
48. Pena, S. D. J., and Hughes, R.C. Fibronectin-plasma membrane interactions in the adhesion and spreading of human fibroblasts. Nature (Lond.), 276: ;80-83, 1978.
49. Dennis, J., Waller, C., Timpl, R., and Schirrmacher, V. Surface sialic acid reduces attachment of metastatic tumor cells to collagen type IV and flbronectin. Nature (Lond.), 300: 274-276,1982.
50. Pouyssegur, J., Willingham, M., and Pastan, I. Role of cell surface carbohydrates and proteins in cell behavior: studies on the biochemical reversion of an N-acetylglucosamine-deflcient fibroblast mutant. Proc. Natl. Acad. Sci. USA, 74: 243-247, 1977.
51. Duksin, D., and Bomstein, P. Changes in surface properties of normal and transformed cells caused by tunicamycin, an inhibitor of protein glycosylation. Proc. Natl. Acad. Sci. USA, 74:;3433-3437, 1977.
52. Pratt, R. M., Olden, K., Yamada, K.M., Ohanian, S. H., and Hascall, V. C. Tunicamycin-induced alterations in the synthesis of sulfated proteoglycans and cell surface morphology in the chick embryo fibroblast. Exp. Cell Res., 18: 245-252, 1979.
53. Butters, T. D., Devalia, V., Aplin, J. A., and Hughes, R. C. Inhibition of fibronectin-inediated adhesion of human fibroblasts to substratum: effects of tunicamycin and some cell surface modifying reagents. J. Cell Sci., 44: 33-58, 1980.
54. Nicolson, G. L., Irimura, T., Gonzalez, R., and Ruoslahti, E. The role of fibronectin in adhesion of metastatic melanaoma cells to endothelial cells and their basal lamina. Exp. Cell Res., 135: 461-465, 1981.
55. Schirrmacher, V., Cheingsong-Popov, R., and Arnheiter, H. Hepatocyte-tumor cell interaction in vitro.; I. Conditions for rosette formation and inhibition by anti-H-2 antibody. J. Exp. Med., 151: 984-989, 1980.
56. Cheinsong-Popov, R., Robinson, S., Altevogt, P., and Schirrmacher, V. A mouse hepatocyte carbohydrate-specific receptor and its interaction with liver-metastasizing tumor cells. Int. J. Cancer, 32:; 356-366,1983.
57. Springer, G. F., Cheingsong-Popov, R., Schirrmacher, V., Desai, P. R., and Tegtmeyer, H. Proposed molecular basis of murine tumor cell-hepatocyte interaction. J. Biol. Chem., 258: 5702-5706,1983.
58. Barsky, S. H., Rao, C.N., Williams, J.E., and Liotta, L.A. Laminin molecular domains which alter metastasis in a murine model. J. Clin. Invest., 74: 843-848, 1984.
59. Sharon, N. Complex Carbohydrates. Their Chemistry, Biosynthesis and Functions, pp. 1-466. Reading, MA: Addison-Wesley Publishing Co., 1975.
60. Bemacki, R., Porter, C., Korytnyk, W., and Mihich, E. Plasma membrane as a site for chemotherapeutic intervention. Adv. Enzyme Regul., 16: 217-237, 1978.
61. Dennis, J. W., Donaghue, T. P., Carlow, D. A., and Kerbel, R. S. Demonstration of a correlation between tumor cell H-2 antigen content, immunogenicity, and tumorigenicity using lectin-resistant tumor variants. Cancer Res., 41: 4010-4019,1981.
62. Schauer, R. Sialic acids and their role as biological masks. Trends Biochem. Sci., 10:; 357-360 (1985).
63. Reading, C. L. Carbohydrate structure, biological recognition, and immune function. In:; R. J. Ivatt (ed.), The Biology of Glycoproteins, pp. 235-321. New York: Plenum Press, 1985.